CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 192 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7 | -22.2% | 586 | -12.8% | 0.01% | -28.6% |
| Q2 2023 | $9 | -76.3% | 672 | -70.8% | 0.01% | -78.8% |
| Q1 2023 | $38 | -53.7% | 2,303 | -47.6% | 0.03% | 0.0% |
| Q4 2022 | $82 | -99.7% | 4,392 | +95.2% | 0.03% | +26.9% |
| Q3 2022 | $29,000 | -9.4% | 2,250 | -50.3% | 0.03% | +4.0% |
| Q2 2022 | $32,000 | -20.0% | 4,530 | -7.1% | 0.02% | -7.4% |
| Q1 2022 | $40,000 | +900.0% | 4,878 | +768.0% | 0.03% | +350.0% |
| Q4 2021 | $4,000 | – | 562 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
| March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
| TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
| PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
| Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
| Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
| Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
| TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
| Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |